ACM
Altium Capital Management Portfolio holdings
AUM
$34.4M
This Quarter Return
-13.66%
1 Year Return
-2.5%
3 Year Return
+357.21%
5 Year Return
–
10 Year Return
–
AUM
$34.4M
AUM Growth
+$34.4M
(-89%)
Cap. Flow
-$273M
Cap. Flow
% of AUM
-793.69%
Top 10 Holdings %
Top 10 Hldgs %
87.51%
Holding
68
New
4
Increased
–
Reduced
18
Closed
43
Top Buys
| 1 |
Intelligent Bio Solutions
INBS
|
$215K |
| 2 |
Sharps Technology
STSS
|
$110K |
| 3 |
LGMK
LogicMark
LGMK
|
$107K |
| 4 |
SBFM
Sunshine Biopharma
SBFM
|
$96.4K |
Top Sells
| 1 |
ADMA Biologics
ADMA
|
$23.9M |
| 2 |
Vera Therapeutics
VERA
|
$18.3M |
| 3 |
Sarepta Therapeutics
SRPT
|
$15.4M |
| 4 |
Establishment Labs
ESTA
|
$14.1M |
| 5 |
Edwards Lifesciences
EW
|
$12.2M |
Sector Composition
| 1 | Healthcare | 99.81% |
| 2 | Consumer Staples | 0.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Zevra Therapeutics
ZVRA
$509M
| $9.64M | 23.23% | 1,287,333 -562,667 | -30% | -$4.21M |
|
2
Evolus
EOLS
$494M
| $3.56M | 8.59% | 296,193 -388,807 | -57% | -$4.68M |
|
3
Xtant Medical Holdings
XTNT
$83.3M
| $3.41M | 8.21% | 7,252,998 -162,415 | -2% | -$76.3K |
|
|
AVDL
4
Avadel Pharmaceuticals
AVDL
$1.43B
| $3.28M | 7.91% | 419,131 -33,344 | -7% | -$261K |
|
|
CTNM
5
Contineum Therapeutics
CTNM
$293M
| $2.12M | 5.11% | 303,857 -30,143 | -9% | -$210K |
|
|
PROF
6
Profound Medical
PROF
$134M
| $2.1M | 5.06% | 360,589 -124,411 | -26% | -$724K |
|
7
Xenon Pharmaceuticals
XENE
$2.98B
| $2.02M | 4.87% | 60,251 -227,749 | -79% | -$7.64M |
|
8
ESSA Pharma
EPIX
$11.4M
| $1.66M | 4% | 1,050,369 -377,631 | -26% | -$597K |
|
9
Skye Bioscience
SKYE
$108M
| $1.44M | 3.47% | 904,865 -234,135 | -21% | -$372K |
|
|
ACOG
10
Alpha Cognition Inc. Common Stock
ACOG
$134M
| $898K | 2.16% | 177,416 -97,584 | -35% | -$494K |
|
11
Rezolute
RZLT
$619M
| $881K | 2.12% | 303,949 -1,390,051 | -82% | -$4.03M |
|
12
Nektar Therapeutics
NKTR
$568M
| $715K | 1.72% | 1,051,379 -1,948,621 | -65% | -$1.33M |
|
|
AVR
13
Anteris Technologies Global Corp. Common Stock
AVR
$145M
| $614K | 1.48% | 168,589 -568,411 | -77% | -$2.07M |
|
14
Larimar Therapeutics
LRMR
$310M
| $587K | 1.42% | 273,204 -231,796 | -46% | -$498K |
|
15
ProMIS Neurosciences
PMN
$28M
| $399K | 0.96% | 574,248 -7,147 | -1% | -$4.97K |
|
16
enVVeno Medical
NVNO
$15.4M
| $324K | 0.78% | 123,256 -186,744 | -60% | -$491K |
|
|
17
Intelligent Bio Solutions
INBS
$14.5M
| $215K | 0.52% | +149,252 | New | +$215K |
|
18
Karyopharm Therapeutics
KPTI
$61.7M
| $185K | 0.44% | 49,333 -690,667 | -93% | -$2.58M |
|
|
19
Sharps Technology
STSS
$13.9M
| $110K | 0.27% | +4,044,149 | New | +$110K |
|
|
LGMK
20
DELISTED
LogicMark
LGMK
| $107K | 0.26% | +5,395,308 | New | +$107K |
|
|
SBFM
21
Sunshine Biopharma
SBFM
$6.56M
| $96.4K | 0.23% | +50,466 | New | +$96.4K |
|
|
SRXH
22
SRX Health Solutions, Inc.
SRXH
$13.9M
| $67.1K | 0.16% | 38,984 -79,475 | -67% | -$137K |
|
23
Glaukos
GKOS
$5.5B
| – | – | -40,000 | Closed | -$6M |
|
24
ImmunityBio
IBRX
$2.21B
| – | – | -1,060,000 | Closed | -$2.71M |
|
25
Insmed
INSM
$28.8B
| – | – | -132,000 | Closed | -$9.11M |
|